Rodica Pop-Busui1, Barbara H Braffett2, Bernie Zinman3, Catherine Martin4, Neil H White5, William H Herman4, Saul Genuth6, Rose Gubitosi-Klug6. 1. Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI rpbusui@umich.edu. 2. Biostatistics Center, The George Washington University, Rockville, MD. 3. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. 4. Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. 5. Washington University in St. Louis, St. Louis, MO. 6. Case Western Reserve University, Cleveland, OH.
Abstract
OBJECTIVE: To examine whether cardiovascular autonomic neuropathy (CAN) is an independent risk factor of cardiovascular disease (CVD) events during DCCT/EDIC. RESEARCH DESIGN AND METHODS: Standardized cardiovascular autonomic reflex tests (R-R response to paced breathing, Valsalva maneuver, postural changes in blood pressure) were performed at DCCT baseline, every 2 years throughout DCCT, and at two time points in EDIC. CVD events were ascertained throughout the study and adjudicated by a review committee. Cox proportional hazards models were used to estimate the effect of CAN at DCCT closeout on subsequent CVD risk. RESULTS: There were 299 adjudicated CVD events in 165 participants following the DCCT closeout assessment: 132 of 1,262 subjects (10%) without CAN at DCCT closeout who experienced 244 CVD events versus 33 of 131 subjects (25%) with CAN at DCCT closeout who experienced 55 events (hazard ratio 2.79, 95% CI 1.91-4.09 for time to first CVD event). The cumulative incidence of the first occurrence of any CVD event during EDIC was significantly higher in participants with CAN at DCCT closeout compared with those without CAN. The association remained marginally significant after adjustment for multiple risk factors, including the EDIC updated mean HbA1c. When analyzed as a continuous variable, R-R variation was significantly lower at DCCT closeout in participants who experienced a CVD event compared with those who did not (P = 0.0012). CONCLUSIONS: In the DCCT/EDIC cohort, individuals diagnosed with CAN at DCCT closeout experienced a higher long-term risk of CVD events during follow-up in EDIC. This association was not independent of historic glycemic exposure and its metabolic memory effect, the principal determinant of both long-term CVD risk and CAN in type 1 diabetes.
RCT Entities:
OBJECTIVE: To examine whether cardiovascular autonomic neuropathy (CAN) is an independent risk factor of cardiovascular disease (CVD) events during DCCT/EDIC. RESEARCH DESIGN AND METHODS: Standardized cardiovascular autonomic reflex tests (R-R response to paced breathing, Valsalva maneuver, postural changes in blood pressure) were performed at DCCT baseline, every 2 years throughout DCCT, and at two time points in EDIC. CVD events were ascertained throughout the study and adjudicated by a review committee. Cox proportional hazards models were used to estimate the effect of CAN at DCCT closeout on subsequent CVD risk. RESULTS: There were 299 adjudicated CVD events in 165 participants following the DCCT closeout assessment: 132 of 1,262 subjects (10%) without CAN at DCCT closeout who experienced 244 CVD events versus 33 of 131 subjects (25%) with CAN at DCCT closeout who experienced 55 events (hazard ratio 2.79, 95% CI 1.91-4.09 for time to first CVD event). The cumulative incidence of the first occurrence of any CVD event during EDIC was significantly higher in participants with CAN at DCCT closeout compared with those without CAN. The association remained marginally significant after adjustment for multiple risk factors, including the EDIC updated mean HbA1c. When analyzed as a continuous variable, R-R variation was significantly lower at DCCT closeout in participants who experienced a CVD event compared with those who did not (P = 0.0012). CONCLUSIONS: In the DCCT/EDIC cohort, individuals diagnosed with CAN at DCCT closeout experienced a higher long-term risk of CVD events during follow-up in EDIC. This association was not independent of historic glycemic exposure and its metabolic memory effect, the principal determinant of both long-term CVD risk and CAN in type 1 diabetes.
Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245
Authors: Dan Ziegler; Christian P Zentai; Siegfried Perz; Wolfgang Rathmann; Burkhard Haastert; Angela Döring; Christa Meisinger Journal: Diabetes Care Date: 2007-12-17 Impact factor: 19.112
Authors: Sabita S Soedamah-Muthu; Nish Chaturvedi; Daniel R Witte; Lynda K Stevens; Massimo Porta; John H Fuller Journal: Diabetes Care Date: 2008-03-28 Impact factor: 19.112
Authors: Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov Journal: Heart Fail Rev Date: 2018-05 Impact factor: 4.214
Authors: Mamta Jaiswal; Jasmin Divers; Elaine M Urbina; Dana Dabelea; Ronny A Bell; David J Pettitt; Giuseppina Imperatore; Catherine Pihoker; Lawrence M Dolan; Angela D Liese; Santica Marcovina; Barbara Linder; Eva L Feldman; Rodica Pop-Busui Journal: Pediatr Diabetes Date: 2018-01-02 Impact factor: 4.866
Authors: Troels S Jensen; Pall Karlsson; Sandra S Gylfadottir; Signe T Andersen; David L Bennett; Hatice Tankisi; Nanna B Finnerup; Astrid J Terkelsen; Karolina Khan; Andreas C Themistocleous; Alexander G Kristensen; Mustapha Itani; Søren H Sindrup; Henning Andersen; Morten Charles; Eva L Feldman; Brian C Callaghan Journal: Brain Date: 2021-07-28 Impact factor: 13.501
Authors: Sareh Keshavarzi; Barbara H Braffett; Rodica Pop-Busui; Trevor J Orchard; Elsayed Z Soliman; Gayle M Lorenzi; Annette Barnie; Amy B Karger; Rose A Gubitosi-Klug; Samuel Dagogo-Jack; Andrew D Paterson Journal: Diabetes Care Date: 2021-02-25 Impact factor: 19.112
Authors: Barbara H Braffett; Rose A Gubitosi-Klug; James W Albers; Eva L Feldman; Catherine L Martin; Neil H White; Trevor J Orchard; Maria Lopes-Virella; John M Lachin; Rodica Pop-Busui Journal: Diabetes Date: 2020-02-12 Impact factor: 9.461
Authors: Ionut Bebu; Barbara H Braffett; David Schade; William Sivitz; John I Malone; Rodica Pop-Busui; Gayle M Lorenzi; Pearl Lee; Victoria R Trapani; Amisha Wallia; William H Herman; John M Lachin Journal: Diabetes Care Date: 2020-08-11 Impact factor: 19.112